Sequential CT Findings in Non-Small Cell Lung Cancer Patients Receiving Nivolumab

Nivolumab is a novel immunotherapy for non-small cell lung cancer (NSCLC). Patients that receive this treatment may show variable CT features on follow-up imaging. We identified patients with NSCLC who received Nivolumab and reviewed their pre- and post-treatment CT scans. We found variable patterns of findings in those who ultimately respond to treatment.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2yTcP6m
via IFTTT